CLINICAL_TRIALS
trial_result
· 2023-03-06
Clinical Trial Update: Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial update on tenapanor as an adjunct to phosphate binder therapy for hyperphosphatemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardelyx | Conditions: Hyperphosphatemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-03-06